Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 5/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.37 |
| ▸ | MYC | P01106 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL8139523 | 0.98 | HPGD (0.40) | HPGDCYP2C9ALDH1A1KDM4EGAA | |
| SCHEMBL30032075 | 0.88 | PDK1 (0.42) | CYP2C9ALDH1A1KDM4EGAAATM | |
| SCHEMBL1826833 | 0.81 | GABRA1 (0.41) | HPGDCYP2C9ALDH1A1KDM4EGAA | |
| SCHEMBL31503044 | 0.80 | TSHR (0.39) | HPGDCYP2C9ALDH1A1KDM4EGAA | |
| SCHEMBL20563882 | 0.80 | MYC (0.42) | HPGDCYP2C9ALDH1A1KDM4EGAA | |
| SCHEMBL3633862 | 0.78 | GABRA1 (0.42) | HPGDCYP2C9ALDH1A1KDM4EGAA | |
| SCHEMBL2792373 | 0.78 | CYP2C9 (0.55) | HPGDCYP2C9ALDH1A1GAANPSR1 | |
| Ammonia Solution, Strong SCHEMBL28714249 | 0.77 | GABRA1 (0.41) | HPGDCYP2C9ALDH1A1KDM4EGAA | |
| SCHEMBL7186121 | 0.77 | CYP1A2 (0.43) | HPGDCYP2C9ALDH1A1KDM4EGAA | |
| SCHEMBL17420628 | 0.77 | PDK1 (0.42) | HPGDALDH1A1KDM4EGAAATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 659 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118420658-B | Preparation method of chiral triazine compound | 天津辰欣药物研究有限公司 | 2024-09-20 | — | — | CN | claimed |
| CN-118420658-A | Preparation method of chiral triazine compound | 天津辰欣药物研究有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-117946102-A | Non-nefardone diastereomer salt and method for preparing non-nefardone by using same | 江苏德源药业股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| WO-2007075630-A1 | METHOD FOR PRODUCING 3-AMINOPIPERIDINE DIASTEREOMER | DOW GLOBAL TECHNOLOGIES INC. (US) | 2007-07-05 | — | — | WO | claimed |
| US-20250177349-A1 | ARYL ALKYNAMIDE DERIVATIVES | Astellas Engineered Small Molecules US, Incorporated | 2025-06-05 | — | — | US | disclosed |
| CN-119768398-A | Heterocyclic compounds which inhibit and/or induce KRAS protein degradation | 安斯泰来制药有限公司 | 2025-04-04 | — | — | CN | disclosed |
| WO-2025068950-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2025-04-03 | — | — | WO | disclosed |
| CN-119451569-A | Preparation method of non-human primate model for cerebral infarction and pharmaceutical composition for cerebral infarction treatment | 安斯泰来制药株式会社 | 2025-02-14 | — | — | CN | disclosed |
| CN-119317620-A | Azacycloalkyl carbonyl cyclic amine compounds | 亚力维克希斯股份有限公司 | 2025-01-14 | — | — | CN | disclosed |
| EP-4486720-A1 | ARYL ALKYNAMIDE DERIVATIVES | Astellas Pharma, Inc. (JP) | 2025-01-08 | — | — | EP | disclosed |
| CN-119110802-A | Heterocyclic derivatives substituted with a middle or macrocyclic benzyl group and related uses | 森特萨制药(英国)有限公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-113365994-B | Pyridazinyl thiazole carboxamides | 安斯泰来制药株式会社 | 2024-08-09 | — | — | CN | disclosed |
| US-3976778-A | ANTHELMINTIC, BACTERICIDE, ANTIPROTOZOA | CIBA-GEIGY CORPORATION (US) | 1976-08-24 | — | — | US | disclosed |
| US-3974280-A | Benzothiophenes | CIBA-GEIGY CORPORATION (US) | 1976-08-10 | — | — | US | disclosed |
| US-3973024-A | Analgesic and anti-inflammatory anilino-phenylacetic acid-(2,3 or 4 pyridyl)-methyl esters and derivatives | CIBA-GEIGY CORPORATION (US) | 1976-08-03 | — | — | US | disclosed |
| US-3956335-A | HYPERTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
| US-3949088-A | Substituted phenoxy propanol amines used for treating cardiovascular diseases | SAMUELSSON BENNY ROGER | 1976-04-06 | — | — | US | disclosed |
| US-3944589-A | α-Cycloalkenylphenyl-fatty acid nitriles | CIBA-GEIGY CORPORATION (US) | 1976-03-16 | — | — | US | disclosed |
| US-3935259-A | 2-HYDROXY-3-(UREIDOPHENOXY)PROPYL, CARDIAC BETA RECEPTOR INHIBITORS | CIBA-GEIGY CORPORATION (US) | 1976-01-27 | — | — | US | disclosed |
| US-3933802-A | New sulphamoylbenzoic acid amides | CIBA-GEIGY CORPORATION (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250177349-A1 | ARYL ALKYNAMIDE DERIVATIVES | STING1, IRF3, TBK1 | HPGD 3987/4885CYP2C9 4741/4885ALDH1A1 3269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.